Third Harmonic Bio pulls in $105m Series B
Third Harmonic Bio, a clinical-stage company, has raised $105 million in Series B funding.
Third Harmonic Bio, a clinical-stage company, has raised $105 million in Series B funding.
Copyright PEI Media
Not for publication, email or dissemination